The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 210.50
Bid: 210.50
Ask: 212.00
Change: -1.50 (-0.71%)
Spread: 1.50 (0.713%)
Open: 207.00
High: 212.00
Low: 207.00
Prev. Close: 212.00
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

16 Apr 2012 14:03

RNS Number : 4159B
Advanced Medical Solutions Grp PLC
16 April 2012
 



For filings with issuer exclude the annex

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ADVANCED MED.SLTN.GP.

 

2. Reason for the notification  (please tick the appropriate box or boxes)

 

An acquisition or disposal of voting rights

X

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify): ___________

 

3. Full name of person(s) subject to the notification obligation:

Ignis Investment Services Limited

 

4. Full name of shareholder(s) (if different from 3.):

 

5. Date of the transaction and date on which the threshold is crossed or reached if different:

13/04/2012

 

6. Date on which issuer notified:

16/04/2012

 

7. Threshold(s) that is/are crossed or reached:

4%

 

 

 

8.Notified details: Nominee holdings

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights viii

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

0453659

6,577,730

3.23%

 

B: Financial Instruments

 

Resulting situation after the triggering transaction xii

 

Type of financial instrument

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

CFD's

 

1,449,690

 

 

0.71%

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration Date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

 

8,027,420.00

3.94%

 

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Vidacos Nominees Ltd (5,765,291.00 2.83%)

State Street Nominees (812,439.00 0.40%)

HSBC (778,690.00 0.38%)

Merrill Lynch (671,000.00 0.33%)

 

 

 

 

 

 

 

Phoenix Group Holdings

Impala Holdings Limited

Ignis Asset management Ltd

Ignis Investment Services Ltd (indirect)

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

Percentage calculation based on Issued Share Capital of 203620367

14. Contact name:

Stuart Caldwell

15. Contact telephone number:

0141 222 8128

 

Note: Annex should only be submitted to the FSA not the issuer

 

Annex: Notification of major interests in shares

A: Identity of the persons or legal entity subject to the notification obligation

Full name (including legal form of legal entities)

Stephanie Griffin

Contact address (registered office for legal entities)

50 Bothwell Street, Glasgow, G2 6HR

Phone number & email

0141 222 8286

Other useful information (at least legal representative for legal persons)

Stephanie Griffin

 

 

B: Identity of the notifier, if applicable

 

Full name

Stuart Caldwell

 

Contact address

50 Bothwell Street, Glasgow, G2 6HR

 

Phone number

0141 222 8128

 

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

Settlements Support Manager

 C: Additional information

 

 

 

For notes on how to complete form TR-1 please see the FSA website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUNVURUKASAAR
Date   Source Headline
8th Jan 20215:37 pmRNSHolding(s) in Company
31st Dec 202010:00 amRNSTotal Voting Rights
15th Dec 20209:47 amRNSHolding(s) in Company
30th Nov 20201:29 pmRNSTotal Voting Rights
23rd Nov 20207:00 amRNSAMS Acquisition of Raleigh Coatings
20th Nov 20207:00 amRNSCE mark approval for Silicone PHMB Foam Dressing
16th Nov 20201:29 pmRNSHoldings in Company
19th Oct 20203:29 pmRNSHolding(s) in Company
16th Sep 20207:00 amRNSInterim Results
15th Sep 20202:48 pmRNSBlock listing Interim Review
3rd Sep 20207:00 amRNSNotice of Results
14th Aug 202012:02 pmRNSPrice Monitoring Extension
4th Aug 20207:00 amRNSUK and US Patents Granted for LiquiBand® Exceed
31st Jul 20201:29 pmRNSTotal Voting Rights
9th Jul 20207:00 amRNSTrading Update
30th Jun 20205:52 pmRNSTotal Voting Rights
19th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 202012:02 pmRNSPrice Monitoring Extension
10th Jun 202011:30 amRNSResult of Annual General Meeting
10th Jun 20207:00 amRNSAGM Trading and US LiquiBand® Update
29th May 20202:17 pmRNSTotal Voting Rights
18th May 20207:00 amRNSAnnual Report, AGM and Board Change
12th May 20206:16 pmRNSDirector/PDMR Shareholding
11th May 20204:01 pmRNSDirector/PDMR Shareholding
30th Apr 20202:00 pmRNSTotal Voting Rights
17th Apr 20204:30 pmRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSPCA Dealing
6th Apr 20209:26 amRNSDirector/PDMR and PCA Shareholding
6th Apr 20207:01 amRNSClinical Development Programme
6th Apr 20207:00 amRNSDirector/PDMR Shareholding
2nd Apr 20207:00 amRNSCOVID-19 Update
30th Mar 20209:06 amRNSHoldings in Company
13th Mar 20205:00 pmRNSHolding(s) in Company
11th Mar 20207:00 amRNSUnaudited Preliminary Results
10th Mar 20207:00 amRNSBlock listing Interim Review
10th Mar 20207:00 amRNSFDA Approval of LiquiBand® Rapid(TM)
11th Feb 202010:03 amRNSHolding(s) in Company
15th Jan 20207:00 amRNSYear End Trading Update
31st Dec 201912:18 pmRNSTotal Voting Rights
2nd Dec 20197:00 amRNSAcquisition of Biomatlante SA
29th Nov 20193:08 pmRNSTotal Voting Rights
29th Nov 20197:00 amRNSThird party sterilisation failure
31st Oct 20193:13 pmRNSTotal Voting Rights
31st Oct 20193:09 pmRNSHolding(s) in Company
16th Sep 201911:15 amRNSHolding(s) in Company
16th Sep 20197:00 amRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNSInterim Results
6th Sep 20197:00 amRNSBlock listing Interim Review
8th Aug 20197:00 amRNSNotice of Interim Results
31st Jul 20195:52 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.